GRCE EPS Estimates
Grace Therapeutics, Inc.
$1.96
+$0.07(+3.70%)
32
Overall
60
Value
10
Tech
26
Quality
Market Cap
$39.76M
Volume
9.33K
52W Range
$1.79 - $5.18
Target Price
$6.00
GRCE EPS estimates: the consensus estimate for Grace Therapeutics, Inc.'s current fiscal year is -$0.80 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
GRCE EPS Estimates
- EPS estimate, current year
- $-0.80
- EPS growth, 3-year
- +20.91%
| Fiscal year | EPS |
|---|---|
| 2026 | $-0.47 |
| 2025 | $-0.79 |
| 2024 | $-1.35 |
| 2023 | $-0.95 |
| 2022 | $-0.27 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRCE | $1.96 | +3.7% | 9.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Grace Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW